Pseudomonas aeruginosa (Schroeter) Migula 铜绿假单胞菌多药耐药菌株BAA-2108 BioVector NTCC质粒载体菌种细胞基因保藏中心

Pseudomonas aeruginosa (Schroeter) Migula 铜绿假单胞菌多药耐药菌株BAA-2108

Product category
Bacteria
Product type
Drug-resistant bacterium
Strain designation
PGO2330
Type strain
No
Genome sequenced strain
Yes
Isolation source
Sputum sample
Applications
Antimicrobial resistance research
Drug development

Susceptibility profile
Resistant
Amoxicillin-clavulanate
Ampicillin
Cefalotin
Cefotaxime
Cefoxitin
Cefpodoxime
Cefuroxime
Cefuroxime axetil
Imipenem
Nitrofurantoin
Tetracycline
Tigecycline
Trimethoprim-sulfamethoxazole

Intermediate
Gentamicin
Levofloxacin

Susceptible
Amikacin
Cefepime
Ceftazidime
Ciprofloxacin
Norfloxacin
Comments
This isolate was collected from a sputum sample of a cystic fibrosis patient during a Phase III clinical trial that tested the effectiveness of aerosolized Tobi (Tobramycin). The 1995-1996 clinical trial was conducted by a consortium led by Chiron and later acquired by Novartis AG.

Medium 18: Trypticase Soy Agar/Broth
Temperature
37°C
Atmosphere
Aerobic

Supplier来源:BioVector NTCC Inc.
TEL电话:+86-010-53513060
Website网址: http://www.biovector.net